Table 1 Association between NMT1, TIMM17A, and the combination of the two on LUAD outcome data. Hazard ratios and confidence intervals for overall survival, disease specific survival, and disease-Free survival for the various categorical splits (rows). Whereas TIMM17A was independently associated with overall survival, disease specific survival, and disease-Free survival, NMT1 was only associated with overall survival. The presence of high NMT1 together with high TIMM17A expression significantly had a significant association with worse OS (P = 0.020 as compared to TIMM17A alone).

From: Elevated co-expression of TIMM17A and NMT1 is associated with poor survival in non-small cell lung cancer

 

Overall survival

n = 486, n-event 174

Disease specific survival

n = 446, n-event = 101

Disease free survival

n = 412, n-event = 175

Hazard rate (95% CI)

P value

Hazard rate (95% CI)

P value

Hazard rate (95% CI)

P value

TIMM17A

Low

Reference

0.003

Reference

0.023

Reference

0.030

High

1.59 (1.17, 2.17)

1.60 (1.07, 2.40)

1.40 (1.03, 1.91)

NMT1

Low

Reference

0.017

Reference

0.316

Reference

0.583

High

1.52 ( 1.08, 2.14)

1.27 (0.79, 2.07)

1.12 (0.76, 1.64)

Combined

Low TIMM17A, Low NMT1

Reference

< 0.001

Reference

0.023

Reference

0.049

High TIMM17A, High NMT1

2.43 (1.52, 3.89)

2.10 (1.11, 3.99)

1.71 (1.00, 2.91)

Combined

Others (Low–Low; Low–High; High–Low)

Reference

0.001

Reference

0.040

Reference

0.135

High TIMM17A, High NMT1

1.99 (1.32, 2.99)

1.82 (1.03, 3.22)

1.45 (0.89, 2.35)

P value - added NMT1 effect

0.020

0.311

0.667

P value - NMT:TIMM17A interaction

0.868

0.429

0.671